Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy
Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy
The study is aimed at verifying if a pulmonologist can reliably assess the tumor burden for
 the extractive molecular analysis in ROSE samples obtained with endoscopic sampling
 procedures from intrathoracic lymphadenopathy and pulmonary nodules.
Inclusion Criteria:

 -  Age > 18 years

 -  Indication for endoscopic sampling of suspected malignant lymphadenopathy or pulmonary
 lesion

 -  Written informed consent

 Exclusion Criteria:

 -  High risk conditions for the performance of bronchoscopy and/or EBUS-TBNA

 -  High risk condition for deep sedation (ASA 4)

 -  Pregnancy